KATHLEEN KONDO: Open Payments
NPI 1023046596 · SARATOGA SPRINGS, NY. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.
See the full provider profile for registry, prescribing and billing details.
Industry payments (Sunshine Act)
Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.
$2,062 in 109 payments from 20 companies in 2025. Trend: 2023 $2,352 · 2024 $2,261 · 2025 $2,062
Food & beverage: $2,062
| Company | Payments | Amount |
|---|---|---|
| Novo Nordisk Inc | 17 | $466 |
| PFIZER INC. | 14 | $299 |
| ABBVIE INC. | 23 | $274 |
| GlaxoSmithKline, LLC. | 10 | $157 |
| AstraZeneca Pharmaceuticals LP | 8 | $150 |
| Amgen Inc. | 8 | $145 |
| Astellas Pharma US Inc | 4 | $78 |
| Abbott Laboratories | 3 | $63 |
| Phathom Pharmaceuticals, Inc. | 3 | $57 |
| Axsome Therapeutics, Inc. | 3 | $56 |
Products named: NURTEC ODT, Ozempic, Wegovy, VRAYLAR, TRELEGY ELLIPTA, UBRELVY, FARXIGA, Veozah.
Industry payments across NY — which companies pay providers there.
